First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models

March 23, 2020

Study highlights previously untapped potential of genetically engineered macrophages in immunotherapy for solid tumors. For full press release, click here.